Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Athletic Injuries | 11 | 2024 | 1209 | 3.290 |
Why?
|
Baseball | 4 | 2023 | 95 | 2.870 |
Why?
|
Brain Concussion | 10 | 2021 | 1394 | 2.010 |
Why?
|
Elbow Joint | 3 | 2023 | 356 | 1.970 |
Why?
|
Hockey | 4 | 2018 | 94 | 1.960 |
Why?
|
Spondylolysis | 2 | 2024 | 46 | 1.910 |
Why?
|
Lacerations | 2 | 2023 | 148 | 1.480 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1868 | 1.000 |
Why?
|
Athletes | 6 | 2024 | 1125 | 0.960 |
Why?
|
Eye Protective Devices | 2 | 2015 | 33 | 0.940 |
Why?
|
Sports Medicine | 4 | 2021 | 242 | 0.800 |
Why?
|
Eye Injuries | 2 | 2015 | 227 | 0.750 |
Why?
|
Wrestling | 1 | 2020 | 19 | 0.740 |
Why?
|
Boxing | 1 | 2020 | 17 | 0.740 |
Why?
|
Martial Arts | 1 | 2020 | 29 | 0.730 |
Why?
|
Soccer | 1 | 2022 | 141 | 0.690 |
Why?
|
Fractures, Stress | 4 | 2024 | 200 | 0.650 |
Why?
|
Policy | 2 | 2022 | 511 | 0.630 |
Why?
|
Post-Concussion Syndrome | 2 | 2019 | 238 | 0.560 |
Why?
|
Racquet Sports | 1 | 2016 | 11 | 0.530 |
Why?
|
Low Back Pain | 1 | 2024 | 979 | 0.520 |
Why?
|
Athletic Performance | 1 | 2016 | 105 | 0.510 |
Why?
|
Tarsal Joints | 1 | 2015 | 32 | 0.500 |
Why?
|
Sprains and Strains | 1 | 2015 | 75 | 0.490 |
Why?
|
Head Injuries, Closed | 1 | 2016 | 133 | 0.480 |
Why?
|
Head Protective Devices | 1 | 2016 | 118 | 0.480 |
Why?
|
Temporal Arteries | 1 | 2016 | 148 | 0.470 |
Why?
|
Whole Body Imaging | 1 | 2016 | 278 | 0.470 |
Why?
|
Metatarsal Bones | 1 | 2015 | 111 | 0.460 |
Why?
|
Dancing | 1 | 2015 | 102 | 0.460 |
Why?
|
Arm | 1 | 2016 | 583 | 0.440 |
Why?
|
Aneurysm, False | 1 | 2016 | 257 | 0.430 |
Why?
|
Rhode Island | 3 | 2018 | 349 | 0.390 |
Why?
|
Adolescent | 23 | 2024 | 87810 | 0.380 |
Why?
|
Learning | 1 | 2021 | 1739 | 0.380 |
Why?
|
Musculoskeletal Diseases | 1 | 2016 | 595 | 0.360 |
Why?
|
Physical Examination | 1 | 2016 | 1244 | 0.360 |
Why?
|
Cumulative Trauma Disorders | 1 | 2011 | 148 | 0.340 |
Why?
|
Ambulatory Care | 1 | 2021 | 2781 | 0.340 |
Why?
|
Schools | 3 | 2022 | 1480 | 0.300 |
Why?
|
Joint Instability | 1 | 2015 | 795 | 0.290 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7021 | 0.290 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36290 | 0.280 |
Why?
|
Meningococcal Infections | 3 | 2006 | 78 | 0.280 |
Why?
|
Neisseria meningitidis | 3 | 2006 | 107 | 0.270 |
Why?
|
Incidence | 8 | 2022 | 21392 | 0.250 |
Why?
|
Pneumococcal Vaccines | 1 | 2008 | 397 | 0.240 |
Why?
|
Sports | 2 | 2021 | 700 | 0.230 |
Why?
|
Pneumococcal Infections | 1 | 2008 | 503 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4048 | 0.210 |
Why?
|
Streptococcus pneumoniae | 1 | 2008 | 732 | 0.210 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7818 | 0.190 |
Why?
|
Child | 13 | 2024 | 79806 | 0.190 |
Why?
|
Sports Equipment | 1 | 2021 | 27 | 0.190 |
Why?
|
Humans | 34 | 2024 | 760621 | 0.180 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25942 | 0.180 |
Why?
|
Aircraft | 2 | 2012 | 126 | 0.180 |
Why?
|
Mass Screening | 1 | 2016 | 5423 | 0.180 |
Why?
|
Protective Devices | 1 | 2021 | 72 | 0.180 |
Why?
|
Models, Biological | 1 | 2016 | 9467 | 0.170 |
Why?
|
Czech Republic | 3 | 2008 | 73 | 0.160 |
Why?
|
Skiing | 1 | 2017 | 25 | 0.150 |
Why?
|
Erysipelas | 1 | 1997 | 3 | 0.140 |
Why?
|
Organizational Culture | 1 | 2021 | 506 | 0.140 |
Why?
|
Young Adult | 9 | 2023 | 58741 | 0.140 |
Why?
|
Running | 2 | 2012 | 483 | 0.140 |
Why?
|
Public Policy | 1 | 2021 | 560 | 0.140 |
Why?
|
Male | 17 | 2024 | 359744 | 0.130 |
Why?
|
Rest | 1 | 2021 | 914 | 0.130 |
Why?
|
Virginia | 1 | 2015 | 116 | 0.130 |
Why?
|
Travel | 2 | 2012 | 785 | 0.130 |
Why?
|
Female | 18 | 2024 | 391270 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2024 | 80372 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 558 | 0.120 |
Why?
|
Weight-Bearing | 1 | 2017 | 518 | 0.120 |
Why?
|
Cohort Studies | 3 | 2023 | 41335 | 0.120 |
Why?
|
Health Education | 1 | 2021 | 1049 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 844 | 0.110 |
Why?
|
Facial Injuries | 1 | 2015 | 190 | 0.110 |
Why?
|
Physical Exertion | 1 | 2016 | 662 | 0.110 |
Why?
|
Lower Extremity | 2 | 2019 | 1194 | 0.110 |
Why?
|
Seasons | 1 | 2018 | 1522 | 0.100 |
Why?
|
Puberty | 1 | 2016 | 498 | 0.100 |
Why?
|
Orbit | 1 | 2015 | 446 | 0.100 |
Why?
|
Students | 1 | 2022 | 1730 | 0.100 |
Why?
|
Orthopedics | 1 | 2020 | 892 | 0.100 |
Why?
|
Muscle Contraction | 1 | 2016 | 1201 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7475 | 0.090 |
Why?
|
Craniocerebral Trauma | 1 | 2015 | 491 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15757 | 0.090 |
Why?
|
Age Factors | 4 | 2020 | 18416 | 0.090 |
Why?
|
Risk Factors | 5 | 2024 | 74359 | 0.090 |
Why?
|
Thromboplastin | 1 | 2012 | 286 | 0.090 |
Why?
|
Time Factors | 5 | 2020 | 40165 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2012 | 418 | 0.090 |
Why?
|
Range of Motion, Articular | 1 | 2016 | 1583 | 0.090 |
Why?
|
Fibrinolysis | 1 | 2011 | 332 | 0.080 |
Why?
|
Age Distribution | 2 | 2008 | 2893 | 0.080 |
Why?
|
Meningitis, Pneumococcal | 1 | 2008 | 43 | 0.080 |
Why?
|
United States | 5 | 2022 | 72461 | 0.080 |
Why?
|
Disease Notification | 1 | 2008 | 97 | 0.080 |
Why?
|
Serotyping | 1 | 2008 | 324 | 0.080 |
Why?
|
Military Personnel | 1 | 2017 | 1244 | 0.070 |
Why?
|
Child, Preschool | 6 | 2020 | 42063 | 0.070 |
Why?
|
Neurology | 1 | 2016 | 779 | 0.070 |
Why?
|
Odds Ratio | 1 | 2018 | 9716 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6360 | 0.070 |
Why?
|
Meningitis, Meningococcal | 1 | 2006 | 44 | 0.070 |
Why?
|
Sex Factors | 2 | 2019 | 10547 | 0.060 |
Why?
|
Adult | 11 | 2023 | 219994 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2011 | 1157 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.060 |
Why?
|
Visual Perception | 1 | 2012 | 1374 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3340 | 0.060 |
Why?
|
Computer Simulation | 1 | 2016 | 6218 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Ultrasonography | 1 | 2016 | 5961 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Prospective Studies | 3 | 2016 | 54303 | 0.050 |
Why?
|
Population Surveillance | 1 | 2012 | 2608 | 0.050 |
Why?
|
Wound Healing | 1 | 2012 | 2788 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4925 | 0.050 |
Why?
|
DNA, Bacterial | 1 | 2006 | 1456 | 0.050 |
Why?
|
Bacterial Typing Techniques | 1 | 2001 | 260 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Carrier State | 2 | 2001 | 525 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 1999 | 394 | 0.040 |
Why?
|
Middle Aged | 8 | 2020 | 220352 | 0.040 |
Why?
|
Thrombosis | 1 | 2012 | 3052 | 0.040 |
Why?
|
Leg Injuries | 1 | 2019 | 178 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6068 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2019 | 1033 | 0.030 |
Why?
|
Infant | 4 | 2008 | 36060 | 0.030 |
Why?
|
Anthropometry | 1 | 2019 | 1348 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 1999 | 1155 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2852 | 0.030 |
Why?
|
Diet | 1 | 2011 | 8010 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2019 | 1736 | 0.030 |
Why?
|
Antithrombin III | 1 | 2011 | 129 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6238 | 0.020 |
Why?
|
Competitive Behavior | 1 | 2011 | 77 | 0.020 |
Why?
|
Factor V | 1 | 2011 | 168 | 0.020 |
Why?
|
Family | 1 | 2001 | 3189 | 0.020 |
Why?
|
Hematocrit | 1 | 2011 | 629 | 0.020 |
Why?
|
P-Selectin | 1 | 2012 | 599 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 65017 | 0.020 |
Why?
|
Physical Endurance | 1 | 2011 | 363 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24123 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2008 | 26181 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2011 | 623 | 0.020 |
Why?
|
Immunity, Innate | 1 | 1999 | 3047 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2012 | 983 | 0.020 |
Why?
|
Bone Density | 1 | 2019 | 3534 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8555 | 0.020 |
Why?
|
Phenotype | 2 | 2001 | 16546 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1190 | 0.020 |
Why?
|
Recurrence | 1 | 1997 | 8482 | 0.010 |
Why?
|
Blood | 1 | 2006 | 586 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2006 | 544 | 0.010 |
Why?
|
Prevalence | 1 | 1999 | 15687 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22053 | 0.010 |
Why?
|
Aged | 2 | 2008 | 169152 | 0.010 |
Why?
|
Contact Tracing | 1 | 2001 | 268 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1997 | 7408 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 1997 | 58995 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29658 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39261 | 0.010 |
Why?
|
Genotype | 1 | 2001 | 12960 | 0.000 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_